SMAD3 and diabetes mellitus: Mice with β-cell-specific constitutively-active TGF-β/Smad3 signaling display increased susceptibility to β-cell apoptosis, which is associated with glucose intolerance, β-cell dysfunction, reduced β-cell mass, and diabetes.